(Q34074772)

30 July 2017

1 reference

title

Novel triazole antifungal agents (English)

1 reference

30 July 2017

Hoffman HL

1

1 reference

30 July 2017

Ernst EJ

series ordinal

2

1 reference

30 July 2017

Klepser ME

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

1 reference

30 July 2017

9

1 reference

30 July 2017

3

1 reference

30 July 2017

593-605

1 reference

Resistance of Candida species to fluconazole

30 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.593

Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.593

Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.593

Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.593

Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.593

Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery--case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.593

In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.593

In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.593

21 January 2018

Identifiers

DOI

10.1517/13543784.9.3.593

1 reference

release_xtbg6a5kjrhupntuvjn2mb4pge

30 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xtbg6a5kjrhupntuvjn2mb4pge

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference